Wave Life Sciences
51 hedge funds and large institutions have $388M invested in Wave Life Sciences in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
100% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 11
63.13% more ownership
Funds ownership: 0% → 63.13% (+63%)
11% more funds holding
Funds holding: 46 → 51 (+5)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
15% less capital invested
Capital invested by funds: $456M → $388M (-$67.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$15.4M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$8.13M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.18M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.04M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$970K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NLVP
New Leaf Venture Partners
New York
|
-$4.1M |
| 2 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$1.67M |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$1.16M |
| 4 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
-$628K |
| 5 |
PA
Perceptive Advisors
New York
|
-$594K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LTFS
51
Ladenburg Thalmann Financial Services
Miami,
Florida
| $6K | – | – | – |
|
|
VIA
52
Vident Investment Advisory
Alpharetta,
Georgia
| – | -$628K | -19,342 | Closed |
|
53
RhumbLine Advisers
Boston,
Massachusetts
| – | -$255K | -7,862 | Closed |
|
|
LSC
54
Lesa Sroufe & Co
Seattle,
Washington
| – | -$209K | -6,440 | Closed |
|
|
AIM
55
Acrospire Investment Management
Chicago,
Illinois
| – | -$5K | -164 | Closed |
|
WVE Hedge Fund Activity: Q4 2016 in Review
51 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q4 2016, worth a combined $388M — down 15% from $456M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new WVE positions and 4 closed out — a net gain of 5 holders — while 22 added to existing stakes and 11 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $15.4M. The largest seller was New Leaf Venture Partners, cutting an estimated $4.1M.
- 51 institutional investors held Wave Life Sciences (WVE) as of Q4 2016, up from 46 in Q3 2016.
- Funds reported $388M of Wave Life Sciences stock for Q4 2016, down 15% quarter-over-quarter.
- 9 funds opened new Wave Life Sciences positions in Q4 2016 and 4 closed out, a net change of +5 holders.
- The largest Wave Life Sciences buyer in Q4 2016 was Deerfield Management, an estimated $15.4M added.
- The largest Wave Life Sciences seller in Q4 2016 was New Leaf Venture Partners, an estimated $4.1M sold.
Based on aggregated 13F filings for Q4 2016.